Novartis wins Gilenya reprieve as judge blocks generics, for now
Novartis has won a U.S. federal court order preventing rival generic makers from selling versions of the Swiss drugmaker's top-selling multiple sclerosis medicine Gilenya in the United States, at least until a patent dispute is resolved.
from Reuters: Health News https://reut.rs/2Ncu8du
http://bit.ly/2zwRqiM